Research progress of SARS-CoV-2 on female reproductive health

VernacularTitle:SARS-CoV-2对女性生殖健康的研究进展
Author: Xiuju CHEN ¹ ; Ningxia SUN ¹
Author Information

1. 海军军医大学第二附属医院生殖医学中心，上海　200003
Publication Type:Journal Article
Keywords: Fertility; Ovarian reserve; Pregnancy outcome; Vaccination; SARS-CoV-2
From: Chinese Journal of Reproduction and Contraception 2023;43(5):523-529
CountryChina
Language:Chinese
Abstract: Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) has spread rapidly around the world and triggered a worldwide pandemic. Whether SARS-CoV-2 potentially adversely affects female fertility is unclear now, and more evidence is needed to support the follow-up. Preliminary studies of combined SARS-CoV-2 in pregnancy have found that SARS-CoV-2 may increase the risk of preeclampsia, preterm delivery, and premature rupture of membranes, but does not appear to be associated with a high risk of early miscarriage. Whether SARS-CoV-2 infection will be vertically transmitted and affect the next generation is unclear and requires more evidence supports. With the prevalence of SARS-CoV-2, the development and clinical trials of SARS-CoV-2 vaccine are widely conducted worldwide, and current studies suggest that SARS-CoV-2 vaccination may not have adverse effects on the reproductive system of women. This article briefly reviewed the progress of research on SARS-CoV-2 on female reproductive health in the context of recent years.